The immune response induced by DNA vaccine expressing nfa1 gene against Naegleria fowleri

The pathogenic free-living amoeba, Naegleria fowleri, causes fatal primary amoebic meningoencephalitis in experimental animals and in humans. The nfa1 gene that was cloned from N. fowleri is located on pseudopodia, especially amoebic food cups and plays an important role in the pathogenesis of N. fowleri. In this study, we constructed and characterized retroviral vector and lentiviral vector systems for nfa1 DNA vaccination in mice. We constructed the retroviral vector (pQCXIN) and the lentiviral vector (pCDH) cloned with the egfp-nfa1 gene. The expression of nfa1 gene in Chinese hamster ovary cell and human primary nasal epithelial cell transfected with the pQCXIN/egfp-nfa1 vector or pCDH/egfp-nfa1 vector was observed by fluorescent microscopy and Western blotting analysis. Our viral vector systems effectively delivered the nfa1 gene to the target cells and expressed the Nfa1 protein within the target cells. To evaluate immune responses of nfa1-vaccinated mice, BALB/c mice were intranasally vaccinated with viral particles of each retro- or lentiviral vector expressing nfa1 gene. DNA vaccination using viral vectors expressing nfa1 significantly stimulated the production of Nfa1-specific IgG subclass, as well as IgG levels. In particular, both levels of IgG2a (Th1) and IgG1 (Th2) were significantly increased in mice vaccinated with viral vectors. These results show the nfa1-vaccination induce efficiently Th1 type, as well as Th2 type immune responses. This is the first report to construct viral vector systems and to evaluate immune responses as DNA vaccination in N. fowleri infection. Furthermore, these results suggest that nfal vaccination may be an effective method for treatment of N. fowleri infection.

[1]  S. Stanley,et al.  Recent progress in vaccines for amebiasis. , 2006, Archives of medical research.

[2]  H. Robinson,et al.  Nucleic acid vaccines: an overview. , 1997, Vaccine.

[3]  P. Bramanti,et al.  Acute primary meningoencephalitis from entamoeba Naegleria Fowleri. Report of a clinical case with a favourable outcome. , 1993, Acta neurologica.

[4]  D. Warhurst,et al.  Primary Amoebic Meningoencephalitis in Britain , 1970, British medical journal.

[5]  A. Mustafa Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. , 2001, Current pharmaceutical biotechnology.

[6]  S. Ståhl,et al.  Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. , 1999, Journal of biotechnology.

[7]  R. Hernández-Pando,et al.  A pcDNA-Ehcpadh vaccine against Entamoeba histolytica elicits a protective Th1-like response in hamster liver. , 2009, Vaccine.

[8]  Sun Park,et al.  Production of Nfa1-specific monoclonal antibodies that influences the in vitro cytotoxicity of Naegleria fowleri trophozoites on microglial cells , 2007, Parasitology Research.

[9]  Sun Park,et al.  Role of the Nfa1 Protein in Pathogenic Naegleria fowleri Cocultured with CHO Target Cells , 2005, Clinical Diagnostic Laboratory Immunology.

[10]  Characterization and vaccination of two novel Schistosoma japonicum genes screened from a cercaria cDNA library , 2011, Parasitology Research.

[11]  Ho-Joon Shin,et al.  Molecular Cloning and Characterization of a Gene Encoding a 13.1 kDa Antigenic Protein of Naegleria fowleri , 2001, The Journal of eukaryotic microbiology.

[12]  Kyongmin Kim,et al.  Immunological Characterizations of a Cloned 13.1-Kilodalton Protein from Pathogenic Naegleria fowleri , 2003, Clinical Diagnostic Laboratory Immunology.

[13]  E. Dumonteil,et al.  Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells. , 2010, Vaccine.

[14]  D. Hollis,et al.  Fatty Acid Composition of Neisseria Species as Determined by Gas Chromatography , 1968 .

[15]  P. Leone,et al.  Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity , 2011, Expert opinion on biological therapy.

[16]  R. Strausberg,et al.  Characterization and vaccine potential of a novel recombinant coccidial antigen , 1989, Infection and immunity.

[17]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[18]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[19]  K. Anderson,et al.  Primary amoebic meningoencephalitis. , 1972, Lancet.

[20]  G. B. Karlsson Hedestam,et al.  DNA vaccines: recent developments and future possibilities. , 2006, Human gene therapy.

[21]  S. Gurunathan,et al.  DNA vaccines: a key for inducing long-term cellular immunity. , 2000, Current opinion in immunology.

[22]  Ho-Joon Shin,et al.  Decreasing effect of an anti-Nfa1 polyclonal antibody on the in vitro cytotoxicity of pathogenic Naegleria fowleri. , 2004, Korean Journal of Parasitology.

[23]  G. Visvesvara,et al.  Successful treatment of primary amebic meningoencephalitis. , 1982, The New England journal of medicine.

[24]  Jan Holmgren,et al.  Mucosal immunity and vaccines , 2005, Nature Medicine.

[25]  A. Miller,et al.  Improved retroviral vectors for gene transfer and expression. , 1989, BioTechniques.

[26]  N. Poungvarin,et al.  The fifth nonlethal case of primary amoebic meningoencephalitis. , 1991, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[27]  W. Poon,et al.  Successful treatment of amoebic meningoencephalitis in a Chinese living in Hong Kong , 1993, Clinical Neurology and Neurosurgery.

[28]  Z. Hassan,et al.  Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii , 2012, Parasitology Research.

[29]  G. Visvesvara,et al.  Naegleria and Acanthamoeba infections: review. , 1990, Reviews of infectious diseases.

[30]  J. Adler-Moore,et al.  Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. , 1991, The Journal of antimicrobial chemotherapy.

[31]  D. Hollis,et al.  Fatty Acid Composition of Neisseria Species as Determined by Gas Chromatography , 1968, Journal of bacteriology.

[32]  R. Carter,et al.  Primary amoebic meningo-encephalitis: An appraisal of present knowledge , 1972 .

[33]  J. H. Kim,et al.  Effects of immunization with the rNfa1 protein on experimental Naegleria fowleri‐PAM mice , 2011, Parasite immunology.

[34]  J. Wilschut,et al.  Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity. , 2001, Vaccine.

[35]  J. Mascola,et al.  Vaccines for the prevention of HIV-1 disease. , 2001, Current opinion in immunology.

[36]  S. Shulman,et al.  Primary amoebic meningoencephalitis: a report of two cases and antibiotic and immunologic studies. , 1981, The Journal of infectious diseases.

[37]  C. Culbertson PATHOGENIC NAEGLERIA AND HARTMANNELLA (ACANTHAMOEBA) , 1970, Annals of the New York Academy of Sciences.

[38]  G. Dougan,et al.  Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. , 1999, Immunology today.

[39]  Sun Park,et al.  Vaccination with Lentiviral Vector Expressing the nfa1 Gene Confers a Protective Immune Response to Mice Infected with Naegleria fowleri , 2013, Clinical and Vaccine Immunology.

[40]  K. Dellagi,et al.  DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice. , 2009, Vaccine.